Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) (RAPID STEMI)
This study has been completed.
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.
Information provided by (Responsible Party):
Derek So, University of Ottawa Heart Institute
First received: September 27, 2011
Last updated: April 23, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2013|
|Primary Completion Date:||September 2012 (Final data collection date for primary outcome measure)|